Journal metric profile

PROSTAGLANDINS & OTHER LIPID MEDIATORS

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 2.500 2025 metric year
5-Year Impact Factor 2.600 Longer citation window
JCR Quartile Q3 Subject-category quartile
JCR Category Rank 214/319 Recorded category rank

PROSTAGLANDINS & OTHER LIPID MEDIATORS JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

PROSTAGLANDINS & OTHER LIPID MEDIATORS metric snapshot

PROSTAGLANDINS & OTHER LIPID MEDIATORS has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is ELSEVIER SCIENCE INC. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 2.500. The five-year Journal Impact Factor is 2.600, giving a second citation window for comparison. The journal is recorded in quartile Q3 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 214 out of 319 journals. Based on that rank position, the journal sits within approximately the top 67% of the listed category. Its listed quartile is Q3. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (2.600) is 0.100 points higher than the standard Journal Impact Factor (2.500). Without journal self-citations, the Impact Factor is 2.300, a difference of 0.200 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 0.490. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for PROSTAGLANDINS & OTHER LIPID MEDIATORS lists total cites: 2,416; total articles: 73; citable items: 88. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 10.3 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 8.8 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

PROSTAGLANDINS & OTHER LIPID MEDIATORS is identified in this directory by print ISSN 1098-8823 and electronic ISSN 2212-196X. The publisher is recorded as ELSEVIER SCIENCE INC. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal namePROSTAGLANDINS & OTHER LIPID MEDIATORS
Abbreviated journalPROSTAG OTH LIPID M
PublisherELSEVIER SCIENCE INC
Metric year2025
Overall rank6,322
ISSN1098-8823
eISSN2212-196X
Total cites2,416
Total articles73
Citable items88
Cited half-life10.3 years
Citing half-life8.8 years
JCR-based Journal Impact Factor2.500
5-Year Impact Factor2.600
Impact Factor without journal self-cites2.300
Journal Citation Indicator0.490
JCR Impact Factor quartileQ3
JCR category rank214/319
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of PROSTAGLANDINS & OTHER LIPID MEDIATORS?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for PROSTAGLANDINS & OTHER LIPID MEDIATORS is 2.500 for the 2025 metric year.

What are the JCR quartile and category rank of PROSTAGLANDINS & OTHER LIPID MEDIATORS?

PROSTAGLANDINS & OTHER LIPID MEDIATORS is listed with quartile Q3 and category rank 214/319. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of PROSTAGLANDINS & OTHER LIPID MEDIATORS?

The five-year Journal Impact Factor recorded for PROSTAGLANDINS & OTHER LIPID MEDIATORS is 2.600. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes PROSTAGLANDINS & OTHER LIPID MEDIATORS?

PROSTAGLANDINS & OTHER LIPID MEDIATORS is listed in this directory as being published by ELSEVIER SCIENCE INC.

Additional records from the same publisher or with a similar listed JCR Impact Factor.